Dr Reddy's Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, respectively, according to the US health regulator. As per its latest Enforcement Report, US Food and Drug Administration (USFDA) said a US-based subsidiary of the Hyderabad-based drug major is recalling certain batches of a generic antiepileptic drug in the US market. Princeton-based Dr Reddy's Laboratories, Inc is recalling 4,010 bags of Levetiracetam 0.75 pc in Sodium Chloride Injection (1,000 mg/100 mL) in the US due to labelling mix up, USFDA said. "The infusion bag is incorrectly labelled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL," it added. The company has issued the Class 1 nationwide (US) recall on March 13 this year, the US health regulator noted. As per the USFDA, a Class I recall pertains to .

Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr

Mahindra & Mahindra Financial Services Ltd.

22 Apr 2025, 05:43PM

277.15

0.49%

Investor Presentation

Mahindra & Mahindra Financial Services Ltd - 532720 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Earnings Presentation Q4 FY 2025

pdf

Mazagon Dock Shipbuilders Ltd.

22 Apr 2025, 05:42PM

2755.40

-0.33%

Company Update

Mazagon Dock Shipbuilders Ltd - 543237 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform that Ms. Veni Thapar has been appointed as Part-time Non-official (Independent) Director on the Board of the Company w.e.f. 21.04.2025.

pdf

Mazagon Dock Shipbuilders Ltd.

22 Apr 2025, 05:37PM

2755.40

-0.33%

Company Update

Mazagon Dock Shipbuilders Ltd - 543237 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform that, Dr. Vivek Bhuskute has been appointed as an Part-time Non-official (Independent) Director on the Board of the Company w.e.f. 21.04.2025

pdf

Mahindra & Mahindra Financial Services Ltd.

22 Apr 2025, 05:37PM

277.15

0.49%

Board Meeting

Mahindra & Mahindra Financial Services Ltd - 532720 - Board Meeting Outcome for Outcome Of Board …

BSE India

Outcome of Board Meeting - Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and financial year ended 31st March 2025

pdf